世界の泌尿器科用画像機器市場見通し2019年-2027年

Stratistics MRCが発行した調査報告書(SMRC20JL480)
◆英語タイトル:Urology Imaging Equipment - Global Market Outlook (2019-2027)
◆商品コード:SMRC20JL480
◆発行会社(リサーチ会社):Stratistics MRC
◆発行日:2020年6月30日
◆ページ数:172
◆レポート形式:英語 / PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:医療
◆販売価格オプション(消費税別)
Single UserUSD4,150 ⇒換算¥439,900見積依頼/購入/質問フォーム
Five UserUSD5,250 ⇒換算¥556,500見積依頼/購入/質問フォーム
Global Site LicenseUSD7,500 ⇒換算¥795,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はStratistics MRC社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。Stratistics MRC社の概要及び新刊レポートはこちらでご確認いただけます。

本調査レポートでは、泌尿器科用画像機器の世界市場を広く調査・分析し、エグゼクティブサマリー、序論、市場動向分析、ファイブフォース分析、種類別(受容体型チロシンキナーゼ阻害剤、非受容体型チロシンキナーゼ阻害剤、セリン/スレオニンキナーゼ阻害剤、RHOキナーゼ阻害剤、マルチキナーゼ阻害剤)分析、流通チャネル別分析、用途別分析、エンドユーザー別分析、地域別分析、主要な市場開拓、企業情報など、今後の市場展望をまとめております。
・エグゼクティブサマリー
・序論
・市場動向分析
・ファイブフォース分析
・泌尿器科用画像機器の世界市場規模:種類別(受容体型チロシンキナーゼ阻害剤、非受容体型チロシンキナーゼ阻害剤、セリン/スレオニンキナーゼ阻害剤、RHOキナーゼ阻害剤、マルチキナーゼ阻害剤)
・泌尿器科用画像機器の世界市場規模:流通チャネル別
・泌尿器科用画像機器の世界市場規模:用途別
・泌尿器科用画像機器の世界市場規模:エンドユーザー別
・泌尿器科用画像機器の世界市場規模:地域別
・主要な市場開拓
・企業情報
【レポートの概要】

According to Stratistics MRC, the Global Urology Imaging Equipment market is accounted for $1.38 billion in 2019 and is expected to reach $2.18 billion by 2027 growing at a CAGR of 5.9% during the forecast period. Some of the key factors propelling the market growth include increasing binge eating and consumption of junk foods, neglect towards regular exercise, rising levels of stress, adoption of multimodality imaging technologies, and rise in prevalence of urology diseases. However, product recall and high cost are likely to restraint the market.

By type, the x-ray/fluoroscopy imaging systems segment is projected to grow at the significant rate during the forecast period. Advanced systems including multimodality integration technologies are anticipated to drive the segment. Among urological disorders in humans, prevalence of kidney stone is increasing. According to an article published in the advances in urology, kidney stone affected approximately 12% of the world’s population and it is most common in men within the age of 20 to 49 years.

On the basis of geography, North America region is expected to have considerable market growth during the forecast period, due to the presence of key players, large number of research activities, and highly structured healthcare industry. Moreover, strategies adopted by key players such as product approval & launch and rise in number of patients with urological diseases are anticipated to fuel the growth of the urology imaging equipment market in the region. The US is anticipated to be the most attractive market for urology imaging equipment, with high attractiveness index.

Some of the key players in urology imaging equipment market include Bristol-Myers Squibb Company, Johnson & Johnson, Boehringer Ingelheim International GmbH, Novartis AG, Eisai Co., Ltd., Bayer AG, AstraZeneca plc, Pfizer, Inc., GE Healthcare (General Electric Company), F. Hoffmann-La Roche Ltd, Stryker, Olympus Corporation, Siemens Healthineers, Richard Wolf GmbH, Boston Scientific Corporation, KARL STORZ, CANON MEDICAL SYSTEMS CORPORATION, Koninklijke Philips N.V., and Guerbet.

Types Covered:
• Receptor Tyrosine Kinase Inhibitors
• Non-receptor Tyrosine Kinase Inhibitors
• Serine/Threonine Kinase Inhibitors
• RHO Kinase Inhibitors
• Multikinase inhibitors
• Protein Kinase C Inhibitors
• X-ray/Fluoroscopy Imaging Systems
• Endovision Systems
• Urology Operating Tables
• Ultrasound Systems

Distribution Channels Covered:
• Independent Pharmacies
• Hospital Pharmacies
• Online Pharmacies

Applications Covered:
• Inflammatory Diseases
• Oncology
• Diagnostics
• Interventional

End Users Covered:
• Ambulatory Surgical Centers
• Hospitals
• Specialty Clinics

Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o France
o Italy
o UK
o Spain
o Rest of Europe
• Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o Rest of Asia Pacific
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa

What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2018, 2019, 2020, 2024 and 2027
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic analysis: Drivers and Constraints, Product/Technology Analysis, Porter’s five forces analysis, SWOT analysis, etc.
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements

Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client’s interest (Note: Depends on feasibility check)
• Competitive Benchmarking
o Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

【レポートの目次】

1 Executive Summary

2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions

3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Application Analysis
3.7 End User Analysis
3.8 Emerging Markets
3.9 Impact of Covid-19

4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry

5 Global Urology Imaging Equipment Market, By Type
5.1 Introduction
5.2 Receptor Tyrosine Kinase Inhibitors
5.2.1 Platelet-derived Growth Factor Receptors (PDGFR)
5.2.2 Vascular Endothelial Growth Factor Receptor (VEGFR)
5.2.3 Anaplastic lymphoma kinase (ALK)
5.2.4 Human Epidermal Growth Factor Receptor 2 (HER2)
5.2.5 Estimated Glomerular Filtration Rate (EGFR)
5.3 Non-receptor Tyrosine Kinase Inhibitors
5.3.1 BCR-ABL
5.3.2 Mesenchymal Epithelial Transition Growth Factor (c-MET)
5.3.3 Bruton’s Tyrosine Kinase (BTK) Inhibitors
5.3.4 Spleen Tyrosine Kinase (SYK) Inhibitors
5.3.5 Janus Kinase (JAK) Inhibitor
5.4 Serine/Threonine Kinase Inhibitors
5.5 RHO Kinase Inhibitors
5.6 Multikinase inhibitors
5.7 Protein Kinase C Inhibitors
5.8 X-ray/Fluoroscopy Imaging Systems
5.9 Endovision Systems
5.10 Urology Operating Tables
5.11 Ultrasound Systems

6 Global Urology Imaging Equipment Market, By Distribution Channel
6.1 Introduction
6.2 Independent Pharmacies
6.3 Hospital Pharmacies
6.4 Online Pharmacies

7 Global Urology Imaging Equipment Market, By Application
7.1 Introduction
7.2 Inflammatory Diseases
7.3 Oncology
7.3.1 Renal Cell Cancer
7.3.2 Lung Cancer
7.3.3 Breast Cancer
7.4 Diagnostics
7.5 Interventional

8 Global Urology Imaging Equipment Market, By End User
8.1 Introduction
8.2 Ambulatory Surgical Centers
8.3 Hospitals
8.4 Specialty Clinics

9 Global Urology Imaging Equipment Market, By Geography
9.1 Introduction
9.2 North America
9.2.1 US
9.2.2 Canada
9.2.3 Mexico
9.3 Europe
9.3.1 Germany
9.3.2 UK
9.3.3 Italy
9.3.4 France
9.3.5 Spain
9.3.6 Rest of Europe
9.4 Asia Pacific
9.4.1 Japan
9.4.2 China
9.4.3 India
9.4.4 Australia
9.4.5 New Zealand
9.4.6 South Korea
9.4.7 Rest of Asia Pacific
9.5 South America
9.5.1 Argentina
9.5.2 Brazil
9.5.3 Chile
9.5.4 Rest of South America
9.6 Middle East & Africa
9.6.1 Saudi Arabia
9.6.2 UAE
9.6.3 Qatar
9.6.4 South Africa
9.6.5 Rest of Middle East & Africa

10 Key Developments
10.1 Agreements, Partnerships, Collaborations and Joint Ventures
10.2 Acquisitions & Mergers
10.3 New Product Launch
10.4 Expansions
10.5 Other Key Strategies

11 Company Profiling
11.1 Bristol-Myers Squibb Company
11.2 Johnson & Johnson
11.3 Boehringer Ingelheim International GmbH
11.4 Novartis AG
11.5 Eisai Co., Ltd.
11.6 Bayer AG
11.7 AstraZeneca plc
11.8 Pfizer, Inc.
11.9 GE Healthcare (General Electric Company)
11.10 F. Hoffmann-La Roche Ltd
11.11 Stryker
11.12 Olympus Corporation
11.13 Siemens Healthineers
11.14 Richard Wolf GmbH
11.15 Boston Scientific Corporation
11.16 KARL STORZ
11.17 CANON MEDICAL SYSTEMS CORPORATION
11.18 Koninklijke Philips N.V.
11.19 Guerbet

List of Tables
Table 1 Global Urology Imaging Equipment Market Outlook, By Region (2018-2027) ($MN)
Table 2 Global Urology Imaging Equipment Market Outlook, By Type (2018-2027) ($MN)
Table 3 Global Urology Imaging Equipment Market Outlook, By Receptor Tyrosine Kinase Inhibitors (2018-2027) ($MN)
Table 4 Global Urology Imaging Equipment Market Outlook, By Platelet-derived Growth Factor Receptors (PDGFR) (2018-2027) ($MN)
Table 5 Global Urology Imaging Equipment Market Outlook, By Vascular Endothelial Growth Factor Receptor (VEGFR) (2018-2027) ($MN)
Table 6 Global Urology Imaging Equipment Market Outlook, By Anaplastic lymphoma kinase (ALK) (2018-2027) ($MN)
Table 7 Global Urology Imaging Equipment Market Outlook, By Human Epidermal Growth Factor Receptor 2 (HER2) (2018-2027) ($MN)
Table 8 Global Urology Imaging Equipment Market Outlook, By Estimated Glomerular Filtration Rate (EGFR) (2018-2027) ($MN)
Table 9 Global Urology Imaging Equipment Market Outlook, By Non-receptor Tyrosine Kinase Inhibitors (2018-2027) ($MN)
Table 10 Global Urology Imaging Equipment Market Outlook, By BCR-ABL (2018-2027) ($MN)
Table 11 Global Urology Imaging Equipment Market Outlook, By Mesenchymal Epithelial Transition Growth Factor (c-MET) (2018-2027) ($MN)
Table 12 Global Urology Imaging Equipment Market Outlook, By Bruton’s Tyrosine Kinase (BTK) Inhibitors (2018-2027) ($MN)
Table 13 Global Urology Imaging Equipment Market Outlook, By Spleen Tyrosine Kinase (SYK) Inhibitors (2018-2027) ($MN)
Table 14 Global Urology Imaging Equipment Market Outlook, By Janus Kinase (JAK) Inhibitor (2018-2027) ($MN)
Table 15 Global Urology Imaging Equipment Market Outlook, By Serine/Threonine Kinase Inhibitors (2018-2027) ($MN)
Table 16 Global Urology Imaging Equipment Market Outlook, By RHO Kinase Inhibitors (2018-2027) ($MN)
Table 17 Global Urology Imaging Equipment Market Outlook, By Multikinase inhibitors (2018-2027) ($MN)
Table 18 Global Urology Imaging Equipment Market Outlook, By Protein Kinase C Inhibitors (2018-2027) ($MN)
Table 19 Global Urology Imaging Equipment Market Outlook, By X-ray/Fluoroscopy Imaging Systems (2018-2027) ($MN)
Table 20 Global Urology Imaging Equipment Market Outlook, By Endovision Systems (2018-2027) ($MN)
Table 21 Global Urology Imaging Equipment Market Outlook, By Urology Operating Tables (2018-2027) ($MN)
Table 22 Global Urology Imaging Equipment Market Outlook, By Ultrasound Systems (2018-2027) ($MN)
Table 23 Global Urology Imaging Equipment Market Outlook, By Distribution Channel (2018-2027) ($MN)
Table 24 Global Urology Imaging Equipment Market Outlook, By Independent Pharmacies (2018-2027) ($MN)
Table 25 Global Urology Imaging Equipment Market Outlook, By Hospital Pharmacies (2018-2027) ($MN)
Table 26 Global Urology Imaging Equipment Market Outlook, By Online Pharmacies (2018-2027) ($MN)
Table 27 Global Urology Imaging Equipment Market Outlook, By Application (2018-2027) ($MN)
Table 28 Global Urology Imaging Equipment Market Outlook, By Inflammatory Diseases (2018-2027) ($MN)
Table 29 Global Urology Imaging Equipment Market Outlook, By Oncology (2018-2027) ($MN)
Table 30 Global Urology Imaging Equipment Market Outlook, By Renal Cell Cancer (2018-2027) ($MN)
Table 31 Global Urology Imaging Equipment Market Outlook, By Lung Cancer (2018-2027) ($MN)
Table 32 Global Urology Imaging Equipment Market Outlook, By Breast Cancer (2018-2027) ($MN)
Table 33 Global Urology Imaging Equipment Market Outlook, By Diagnostics (2018-2027) ($MN)
Table 34 Global Urology Imaging Equipment Market Outlook, By Interventional (2018-2027) ($MN)
Table 35 Global Urology Imaging Equipment Market Outlook, By End User (2018-2027) ($MN)
Table 36 Global Urology Imaging Equipment Market Outlook, By Ambulatory Surgical Centers (2018-2027) ($MN)
Table 37 Global Urology Imaging Equipment Market Outlook, By Hospitals (2018-2027) ($MN)
Table 38 Global Urology Imaging Equipment Market Outlook, By Specialty Clinics (2018-2027) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.



【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界の泌尿器科用画像機器市場見通し2019年-2027年(Urology Imaging Equipment - Global Market Outlook (2019-2027))]についてメールでお問い合わせはこちらでお願いします。


◆H&Iグローバルリサーチのお客様(例)◆